Skip to Content

Immuno, Volume 1, Issue 2

2021 June - 3 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (3)

  • Review
  • Open Access
18 Citations
7,481 Views
28 Pages

A Signaling View into the Inflammatory Tumor Microenvironment

  • Joana F. S. Pereira,
  • Peter Jordan and
  • Paulo Matos

15 June 2021

The development of tumors requires an initiator event, usually exposure to DNA damaging agents that cause genetic alterations such as gene mutations or chromosomal abnormalities, leading to deregulated cell proliferation. Although the mere stochastic...

  • Perspective
  • Open Access
10 Citations
5,479 Views
13 Pages

12 May 2021

Like in other neurodegenerative diseases, protein aggregation, mitochondrial dysfunction, oxidative stress and neuroinflammation are hallmarks of Parkinson’s disease (PD). Differentiating characteristics of PD include the central role of α-synuclein...

  • Article
  • Open Access
5 Citations
7,298 Views
11 Pages

LDH Isotyping for Checkpoint Inhibitor Response Prediction in Patients with Metastatic Melanoma

  • Sandra van Wilpe,
  • Sofie H. Tolmeijer,
  • I. Jolanda M. de Vries,
  • Rutger H. T. Koornstra and
  • Niven Mehra

12 April 2021

Serum lactate dehydrogenase (LDH) levels are inversely related with response to immune checkpoint inhibitors (ICIs) in patients with metastatic melanoma. LDH is a key regulator of glycolysis, a pathway known to be upregulated in malignant tumors and...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Immuno - ISSN 2673-5601